Pall Corp. acquires Euroflow, strengthens biotechnology product line

Pall Corp. has acquired Euroflow (UK) of Stroud, England. The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography columns and associated technologies since 2002. Euroflow sales are currently about $5 million a year...

EAST HILLS, NY, Jan. 25, 2005 (BUSINESS WIRE) -- Pall Corp. has acquired Euroflow (UK) of Stroud, England. The company is one of the world's leading manufacturers of pilot and production scale chromatography columns for the biotechnology industry. Pall held exclusive global marketing and distribution rights to Euroflow chromatography columns and associated technologies since 2002. Euroflow sales are currently about $5 million a year.

Pall also recently broadened its position in the chromatography market with its November 2004 acquisition of the BioSepra Process Division from Ciphergen Biosystems, Inc. Pall BioSepra develops, manufacturers and markets chromatography sorbents that greatly simplify protein purification for drug development and production. Both acquisitions target the rapidly growing biotechnology industry and allow Pall to provide a more complete "Total Fluid Management" systems approach to customers. The chromatography market represents about 40% of the total biotech industry potential for filtration and purification technologies.

Eric Krasnoff, chairman and CEO of Pall Corporation, said, "We welcome Euroflow to our growing family of purification technologies. We are responding to the industry's request for integrated systems solutions for purification technologies from development through large-scale production. Pall's Total Fluid Management approach helps customers to consistently meet productivity, quality and regulatory requirements at the lowest cost of ownership."

About Pall Corp.
Pall Corp. (www.pall.com) is a global leader in the rapidly growing field of filtration, separations and purification. It's business is organized around two broad markets: Life Sciences and Industrial. The company provides leading-edge products to meet the demanding needs of customers in biotechnology, pharmaceuticals, transfusion medicine, semiconductors, water purification, aerospace and broad industrial markets. Total revenues are $1.8 billion. Its headquarters are in East Hills, N.Y., with extensive operations throughout the world.

###

More in Technologies